文献速递神经肿瘤

36对原发/复发无功能垂体腺瘤中TGF-β1与WIF1表达的相关性:一项高通量组织芯片免疫组化研究

Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
PubMed 文献 · World Neurosurg · 2018-06-30

研究104例无功能垂体腺瘤患者(59例无复发、45例复发,其中9例一次手术、36例两次手术且双肿瘤均研究),用组织芯片免疫组化检测TGF-β1和WIF1并经qRT-PCR和Western blot确认。发现侵袭、TGF-β1和WIF1与复发显著相关,年龄与TGF-β1和WIF1低表达相关(P < 0.001)。36对原发/复发肿瘤中复发瘤TGF-β1和WIF1表达高于原发瘤。

要点

  • 侵袭、TGF-β1和WIF1与无功能垂体腺瘤复发显著相关。
  • 年龄与TGF-β1和WIF1低表达相关(P < 0.001)。
  • 36对原发/复发肿瘤中复发瘤TGF-β1和WIF1表达高于原发瘤。

核心结论

  • 无功能垂体腺瘤中TGF-β1和WIF1表达与细胞增殖和复发潜能相关,可能是进展行为的好标志物,但生物学机制需进一步研究。

研究设计与样本

  • 研究104例患者,包括59例无复发和45例复发(9例一次手术、36例两次手术且双肿瘤均研究)。
  • 所有组织用组织芯片免疫组化检测TGF-β1和WIF1,并经实时定量逆转录聚合酶链反应(qRT-PCR)和Western blot确认。

主要发现

  • 侵袭、TGF-β1和WIF1与复发显著相关,年龄与TGF-β1和WIF1低表达相关(P < 0.001)。
  • 非侵袭组与侵袭组间两种蛋白表达无统计学显著差异。
  • 复发组原发瘤中TGF-β1和WIF1表达低于无复发组(P < 0.001)。
  • 36对原发/复发肿瘤中,复发瘤TGF-β1和WIF1表达高于原发瘤,经qRT-PCR和Western blot确认。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study was undertaken primarily to research transforming growth factor β1 (TGF-β1) and Wnt inhibitory factor 1 (WIF1) for the prediction of nonfunctioning pituitary adenoma (NFPAs) invasion and recurrence of tumor samples and the relations between quantitatively determined markers and clinical characters. METHODS: We studied 104 patients, including 59 patients without recurrence and 45 patients with recurrence (9 patients with one surgery and 36 patients operated twice, both tumors being studied). All tissues were immunostained for TGF-β1 and WIF1 using tissue microarrays and confirmed with real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot. RESULTS: We found that invasion, TGF-β1, and WIF1 were significantly associated with recurrence and that age was associated with low expression of TGF-β1 and WIF1 (P < 0.001). There were no statistically significant differences in the expression of the 2 proteins between the noninvasive and the invasive groups. The expression of TGF-β1 and WIF1 in primary tumors in the recurrence group was lower than in the nonrecurrence group (P < 0.001). In the 36 paired primary or recurrent tumors, the expression of TGF-β1 and WIF1 in recurrent tumors was higher than the expression of primary tumors, which was confirmed with qRT-PCR and Western blot. Therefore, TGF-β1 and WIF1 seem to be related to recurrence or progression of pituitary adenomas. CONCLUSIONS: The expression of TGF-β1 and WIF1 in NFPAs correlated with cell proliferation and recurrence potential. They may be good markers of progressive behavior in NFPAs; however, the biologic mechanism needs further study.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zhu H, Yao X, Wu L, et al. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study. World Neurosurg. 2018. PMID: 29966778. doi:10.1016/j.wneu.2018.06.154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。